Quest Diagnostics to Host Investor Day on March 19, 2025

13.02.25 22:54 Uhr

Werte in diesem Artikel

SECAUCUS, N.J., Feb. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March 19, 2025 at the New York Stock Exchange. 

Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)

During the event, Jim Davis, Chairman, CEO and President, Sam Samad, Executive Vice President and CFO, and other senior executives will provide updated views of the U.S. laboratory market, and the company's business strategy, capital deployment priorities, and its long-term outlook. Advance registration is required.

To register for the event, please go to: Quest Diagnostics 2025 Investor Day Registration.

A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website

An archived copy of the webcast will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-19-2025-302376570.html

SOURCE Quest Diagnostics

Ausgewählte Hebelprodukte auf Quest Diagnostics

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Quest Diagnostics

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Quest Diagnostics Inc.

Wer­bung

Analysen zu Quest Diagnostics Inc.

DatumRatingAnalyst
25.06.2018Quest Diagnostics OverweightBarclays Capital
20.10.2017Quest Diagnostics BuyMizuho
25.07.2017Quest Diagnostics BuyMizuho
05.06.2017Quest Diagnostics BuyMizuho
12.05.2017Quest Diagnostics HoldArgus Research Company
DatumRatingAnalyst
25.06.2018Quest Diagnostics OverweightBarclays Capital
20.10.2017Quest Diagnostics BuyMizuho
25.07.2017Quest Diagnostics BuyMizuho
05.06.2017Quest Diagnostics BuyMizuho
26.04.2017Quest Diagnostics BuyMizuho
DatumRatingAnalyst
12.05.2017Quest Diagnostics HoldArgus Research Company
07.03.2017Quest Diagnostics Equal WeightBarclays Capital
21.10.2016Quest Diagnostics NeutralMizuho
22.04.2016Quest Diagnostics Equal WeightBarclays Capital
22.04.2016Quest Diagnostics Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quest Diagnostics Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"